株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

夜間多尿症:主要8カ国の市場予測

Epiomic Epidemiology Series: Nocturia Forecast in 8 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 339842
出版日 ページ情報 英文 38 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.19円で換算しております。
Back to Top
夜間多尿症:主要8カ国の市場予測 Epiomic Epidemiology Series: Nocturia Forecast in 8 Major Markets 2015-2025
出版日: 2015年08月11日 ページ情報: 英文 38 Pages
概要

夜間多尿症は比較的多く散見される泌尿器疾患で、排尿のために夜間に何度も眼が覚めるという特徴があります。別の潜在的な疾患・症状 (多尿症、前立腺肥大症 (BPH)、膀胱機能障害など) により引き起こされている場合が多くなっています。

当レポートでは、世界の主要8ヶ国 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本) における夜間多尿症の発症状況について分析し、疾患の概要や現時点での有病者数、性別・年代別 (5歳区切り) の詳細状況、地域別・民族別傾向、リスク要因、疾患の診断と予後、主な症状や合併症、将来的な動向見通し (今後10年間分) といった情報を取りまとめてお届けいたします。

イントロダクション

疾患の原因

リスク要因と予防法

疾患の診断

地域別/民族別の差異

疾患の予後と臨床経過

疾患に関連する主な共存症/特徴

患者数の定量化の手法

夜間多尿症の有病者数

夜間多尿症の主な特徴

  • 病因
  • C反応タンパク質の数値
  • 夜間の排泄の頻度
  • 夜間多尿症の併存症
  • 夜間多尿症患者のBMI数値

文中の略語

Black Swan Analysisのその他の刊行物

患者ベースのオンライン・データベース

患者ベースのサービス

データ・プラットフォームのオンライン価格

参考文献

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: NOCT0010815

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Nocturia in 8 Major Markets

Nocturia is a relatively common urological problem and involves waking up more than twice during the night to void the bladder. Nocturia tends to be caused by other underlying diseases and processes, such as polyuria, Benign Prostatic Hyperplasia (BPH) or bladder storage disorders. This report provides the current prevalent population for Nocturia across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Nocturia. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Nocturia have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Nocturia include:

  • Diabetes
  • Hypertension
  • Multiple sclerosis
  • Urinary Incontinence
  • Benign Prostatic Hyperplasia
  • Chronic Heart Failure
  • Chronic kidney disease
  • Overactive bladder
  • Alcohol consumption

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy:

  • Able to quantify patient populations in global Nocturia's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Nocturia and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Nocturia's prevalent population.
  • Identify sub-populations within Nocturia which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Nocturia patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors and Prevention
  • Diagnosis of the Disease
  • Variation by Geography/ Ethnicity
  • Disease Prognosis and Clinical Course
  • Key Co-Morbid Conditions / Features associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Nocturia
  • Main Features of Nocturia Patients
    • Aetiology
    • C-reactive Protein Status
    • Frequency of Night-Time Voids
    • Concomitant Conditions for Nocturia
    • BMI Status of Patients with Nocturia
  • Abbreviations used in the Report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables and Figures

  • Algorithm for the Definition and Treatment of Nocturia
  • Prevalence of Nocturia, total (000s)
  • Prevalence of Nocturia, males (000s)
  • Prevalence of Nocturia, females (000s)
  • Nocturia Patients by Aetiology, total (000s)
  • Nocturia Patients by CRP level, total (000s)
  • Frequency of Night-Time Voids in Patients with Nocturia, total (000s)
  • Prevalence of Diabetes in Patients with Nocturia, total (000s)
  • Prevalence of Hypertension in Patients with Nocturia, total (000s)
  • Prevalence of BPH in Patients with Nocturia, total (000s)
  • Prevalence of CHF in Patients with Nocturia, total (000s)
  • Prevalence of Urinary Incontinence in Patients with Nocturia, total (000s)
  • Prevalence of Multiple Sclerosis in Patients with Nocturia, total (000s)
  • BMI Status of Patients with Nocturia, total (000s)
  • Abbreviations and Acronyms used in the Report
  • USA Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • USA Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • France Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • France Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Germany Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Germany Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Italy Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Italy Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Spain Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Spain Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Japan Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Japan Prevalence of Nocturia by 5-yr age cohort, females (000s)
Back to Top